WFDC2 and ovarian neoplasm: Several ovarian biomarkers, such as Kallikreins, osteopontin, leptin, HE-4, LPA, MUC1 and SLPI, [3,10,18,42-45] have been identified in the past several years through various approaches, including gene expression profiling and proteomics analysis of ovarian tumors.